Systemic Mastocytosis Successfully Managed using Cytosorb® During Cardiopulmonary Bypass for Aortic Valve Replacement

Autor: Adrien Gross, Sébastien Colombier, Lionel Arlettaz, Dominique Delay

Publikováno v: Annals of Cardiac Anaesthesia, Vol 27, Iss 4, Pp 364-367 (2024)

We describe the case of a 72-year-old male with a history of systemic mastocytosis scheduled for on-pump aortic valve replacement for severe aortic insufficiency. Anesthesia and peri-operative management included avoidance of histamine-releasing drug

Externí odkaz: https://doaj.org/article/b0f1edfec5f3432ca144411f3e5d54a2

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy

Autor: Joerg Scheier, MD, Peter J. Nelson, MD, FASN, Antoine Schneider, MD, PhD, Sébastien Colombier, MD, Detlef Kindgen-Milles, MD, PhD, Efthymios N. Deliargyris, MD, FACC, FESC, FSCAI, Thomas D. Nolin, PharmD, PhD

Publikováno v: Critical Care Explorations, Vol 4, Iss 5, p e0688 (2022)

OBJECTIVE:. The CytoSorb hemoadsorption device (CytoSorbents Inc, Monmouth Junction, NJ) is increasingly used in many critical disease states. The potential impact on the pharmacokinetic (PK) of concomitantly administered drugs must be considered in

Externí odkaz: https://doaj.org/article/125b516ba4524b6db74fc6c9a0163a1f

Type A aortic dissection in aneurysms having modelled pre-dissection maximum diameter below 45 mm: should we implement current guidelines to improve the survival benefit of prophylactic surgery?

Autor: Piergiorgio Tozzi, Francesco Patella, Salah D. Qanadli, Dominique Delay, Lars Niclauss, Matthias Kirsch, Ziyad Gunga, Raymond Pfister, Aurelian Roumy, Sébastien Colombier

Publikováno v: European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
European journal of cardio-thoracic surgery, vol. 59, no. 2, pp. 473-478

OBJECTIVES Current guidelines recommend prophylactic replacement of the ascending aorta at an aneurysmal diameter of >55 mm to prevent acute Type A aortic dissection (TAAD) in non-Marfan patients. Several publications have challenged this threshold,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9beff44a935fe7b343286c4244ef998
http://europepmc.org/articles/PMC7850065

Cytosorb® hemoadsorption of apixaban during emergent cardio-pulmonary bypass: a case report

Autor: Sébastien Colombier, Pierre Schlaepfer, Vitor Mendes, Matthias Kirsch, Emmanuelle Scala, François Verdy, Xavier Bechtold, Antoine G. Schneider

Publikováno v: Perfusion. 36:873-875

Background: Peri-operative coagulation management of patients receiving apixaban, a new oral anticoagulant, is difficult. The CytoSorb® hemoadsorption device might represent a therapeutic option to reduce apixaban’s pharmacological and inflammator

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e423b65e914712bf582ab0603d11574
https://doi.org/10.1177/0267659120967827

Cardiac arrest and COVID-19: inflammation, angiotensin-converting enzyme 2, and the destabilization of non-significant coronary artery disease-a case report

Autor: Thabodhan Mahendiran, Sébastien Colombier, Lars Niclauss, Matthias Kirsch

Publikováno v: European Heart Journal: Case Reports
European Heart Journal-Case Reports
European heart journal. Case reports, vol. 5, no. 1, pp. ytaa475

Background The new β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appears to exhibit cardiovascular pathogenicity through use of angiotensin-converting enzyme 2 (ACE2) for cell entry and the development of a major systemi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925aafd3f8470fc930af268a651fcc9c
https://pubmed.ncbi.nlm.nih.gov/33542974